Insights On Drug Development
-
Expanding Opportunities For Inhaled Drug Delivery
7/11/2025
Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.
-
Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development
7/9/2025
Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.
-
Nitrosamine Testing For Regulatory Readiness
7/8/2025
Discover how delivering ultra-sensitive detection of nitrosamine impurities like NDMA and NDEA helps safeguard pharmaceutical quality and meet evolving global regulatory demands.
-
New Approaches To Tailored Release Profiles
7/7/2025
Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
-
Techniques For PEGylation Site Identification
7/3/2025
Examine how our innovative methods enable the precise identification of PEGylation sites, unlocking deeper insights into the structure, stability, and function of biotherapeutics.
-
Accelerate FDA Approval With Fast Track Designation
7/3/2025
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
Securing A Treatment Through Grit And Collaboration
7/3/2025
Discover how one family defied the odds—bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.
-
CDMO SOWs Must (Re-)Align With New Project Realities
6/26/2025
Decades of experience in cell and gene therapy outsourcing have taught Donna Rill, Chief Technology Officer, Triumvira Immunologics, that the key to success is ensuring CDMOs and sponsors understand the need to continuously align SOWs with the variances as projects move forward.
-
It's Not What You Deserve, It's What You Negotiate
6/26/2025
Seshu Tummala of Uniquity Bio and Reza Oliyai of Oliyai Consulting Corporation discuss how to achieve your (at times evolving) goals and meet the needs of your CDMOs.
-
Your CDMO Knows A Lot - Are You Listening?
6/26/2025
Our three experienced panelists weigh in on how sponsors should take advantage of what CDMOs know from experience in quality, regulatory, and other aspects of development and processing.